The company will not receive any of the proceeds from the sale of the shares by the selling stockholders. Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> See today’s best-performing stocks on TipRanks >> Read More on MBIO: Mustang Bio Faces Nasdaq Delisting and Leadership Changes Mustang Bio receives positive listing determination from Nasdaq Is MBIO a Buy, Before Earnings? Mustang Bio granted Orphan Drug Designation by U.S. FDA for MB-108 Mustang Bio Secures $4M through Strategic Warrant Agreement Disclaimer & DisclosureReport an Issue